Lung cancer tumorigenicity and drug resistance are maintained through ALDH(hi)CD44(hi) tumor initiating cells

Limited improvement in long term survival of lung cancer patients has been achieved by conventional chemotherapy or targeted therapy. To explore the potentials of tumor initiating cells (TIC)-directed therapy, it is essential to identify the cell targets and understand their maintenance mechanisms....

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Liu, Jing, Xiao, Zhijie, Wong, Sunny Kit-Man, Tin, Vicky Pui-Chi, Ho, Ka-Yan, Wang, Junwen, Sham, Mai-Har, Wong, Maria Pik
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2013
Matèries:
Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3858556/
https://ncbi.nlm.nih.gov/pubmed/24091605
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars